IL230282B
Stabilized formulations containing anti-pcsk9 antibodies
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
57 members in 21 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 201161512666 | United States of America | P | |
| 2012048574 | United States of America | W |
Members57
| Document | Office | Kind | |
|---|---|---|---|
| CA2841588A1 | Canada | A1 | |
| WO2013016648A2 | World Intellectual Property Organization (WIPO) | A2 | |
| UY34228A | Uruguay | A | |
| WO2013016648A3 | World Intellectual Property Organization (WIPO) | A3 | |
| TW201322995A | Taiwan Province of China | A | |
| US2013189277A1 | United States of America | A1 | |
| CO6862108A2 | Colombia | A2 | |
| AU2012286663A1 | Australia | A1 | |
| AR087305A1 | Argentina | A1 | |
| CN103717237A | China | A | |
| MX2014000771A | Mexico | A | |
| KR20140061360A | Republic of Korea | A | |
| EA201490370A1 | Eurasian Patent Organization (EAPO) | A1 | |
| EP2736529A2 | European Patent Office (EPO) | A2 | |
| CL2014000183A1 | Chile | A1 | |
| MA35355B1 | Morocco | B1 | |
| US8795669B2 | United States of America | B2 | |
| JP2014525915A | Japan | A | |
| US2014341928A1 | United States of America | A1 | |
| NZ619379A | New Zealand | A | |
| US9193801B2 | United States of America | B2 | |
| US2016032015A1 | United States of America | A1 | |
| AU2012286663B2 | Australia | B2 | |
| JP6045583B2 | Japan | B2 | |
| BR112014001712A2 | Brazil | A2 | |
| AU2017200811A1 | Australia | A1 | |
| JP2017071620A | Japan | A | |
| TWI586366B | Taiwan Province of China | B | |
| EA028227B1 | Eurasian Patent Organization (EAPO) | B1 | |
| MX352529B | Mexico | B | |
| EA201791185A1 | Eurasian Patent Organization (EAPO) | A1 | |
| JP6271682B2 | Japan | B2 | |
| US2018044436A1 | United States of America | A1 | |
| MY165156A | Malaysia | A | |
| AU2017200811B2 | Australia | B2 | |
| JP2018070649A | Japan | A | |
| CN108420788A | China | A | |
| JP6456470B2 | Japan | B2 | |
| KR102001818B1 | Republic of Korea | B1 | |
| CA2841588C | Canada | C | |
| US2019284301A1 | United States of America | A1 | |
| US10472425B2 | United States of America | B2 | |
| IL230282A | Israel | A | |
| IL230282BThis record | Israel | B | |
| US10752701B2 | United States of America | B2 | |
| EA036042B1 | Eurasian Patent Organization (EAPO) | B1 | |
| MX2020010470A | Mexico | A | |
| MX2020010470A | Mexico | A | |
| US2021054100A1 | United States of America | A1 | |
| EA202091373A1 | Eurasian Patent Organization (EAPO) | A1 | |
| BR112014001712B1 | Brazil | B1 | |
| PH12013502602A1 | Philippines | A1 | |
| US11673967B2 | United States of America | B2 | |
| EP4218814A2 | European Patent Office (EPO) | A2 | |
| EP4218814A3 | European Patent Office (EPO) | A3 | |
| US2023406959A1 | United States of America | A1 | |
| MX375672B | Mexico | B |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF |
Numbers
- Publication
- 230282
- Application
- 23028214
Titles2
- English
- Stabilized formulations containing anti-pcsk9 antibodies
- Hebrew
- פורמולציות יציבות המכילות שדה נוגדנים אנטי–9pcsk
Classification
- CPC, 10
- A61K39/395
- C07K16/40
- A61M5/31513
- A61M5/3202
- A61K47/22
- A61K47/26
- C07K2317/94
- A61K39/39591
- A61K39/3955
- C07K2317/565